Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency
Abstract X-linked agammaglobulinemia (XLA) is a rare genetic disorder, caused by mutations in BTK (Bruton’s Tyrosine Kinase) gene. Deep high-throughput RNA sequencing (RNA-Seq) approach was utilized to explore the possible differences in transcriptome profiles of primary monocytes in XLA patients co...
Enregistré dans:
| Auteurs principaux: | Hoda Mirsafian, Adiratna Mat Ripen, Wai-Mun Leong, Chai Teng Chear, Saharuddin Bin Mohamad, Amir Feisal Merican |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b938aa80e2a94cb2a35d82db601e0ff3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Revealing Chronic Granulomatous Disease in a Patient With Williams-Beuren Syndrome Using Whole Exome Sequencing
par: Adiratna Mat Ripen, et autres
Publié: (2021) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
par: Vicente Soriano, et autres
Publié: (2022) -
Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model
par: Hong Wu, et autres
Publié: (2017) -
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
par: Jan A. Burger, et autres
Publié: (2016) -
Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice
par: Susan M. O’Brien, et autres
Publié: (2021)